Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Global CAR T-Cell Therapy Market: Competitor Landscape
In July 2023, Pfizer invested USD 25 million equity investment in Caribou Biosciences to develop and extensive allogeneic CAR-T cell therapy for multiple myeloma. The United States based biotech company will invest the money into CB-011, its allogeneic CAR-T cell therapy, which is being studied in a phase 1 clinical trial in patients. It targets the B-cell maturation antigen and is intended to remove the B2M protein and insert a B2M-HLA-E fusion protein to inhibit immune-mediated rejection.
In December 2023, FUJIFILM also announced their USD 200 million investment in cell therapies. This investment is intended to strengthen the company’s manufacturing capacity to support iPSC-derived cell therapies, as well as chimeric antigen receptor (CAR), T-cell receptor (TCR), cytoxic T lymphocyte (CTL), natural killer (NK) and tissue-derived therapies. The rising investments and portfolio expansions demonstrate a generic market trend wherein several companies are stepping in to solidify their presence in the market.
The key features of the CAR T-cell therapy market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Autolus Therapeutics
- CARsgen Therapeutics Co.Ltd.
- Juno Therapeutics, Inc.
- Sorrento Therapeutics, Inc.
- Bluebird bio, Inc.
- CELGENE CORPORATION
- Eureka Therapeutics Inc.
- Avacta Life Sciences Ltd.
- Calyxt Inc.
- Celyad Oncology SA
- Fortress Biotech, Inc
- IMMUNE THERAPEUTICS, INC
- Alaunos Therapeutics, Inc.
- Novartis AG
- Gilead Sciences, Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
CAR T-Cell Therapy Market Report Snapshots
CAR T-Cell Therapy Market Size
CAR T-Cell Therapy Market Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of about USD 2.5 billion in 2023, driven by the growing prevalence of cancer across the globe.
The market is anticipated to grow at a CAGR of 15.2% during the forecast period of 2024-2032, likely to reach a market value of USD 9 billion by 2032.
The market demand is driven by the rising emphasis on offering personalised treatment to the patients, along with technical advancements and a surge in research and development activities, owing to a better understanding of genetics and cellular biology.
The major market trend involves increasing partnerships and collaborations between influential market players. For instance, In December 2023, AbelZeta and AstraZeneca entered an agreement to develop C-CAR031, an autologous and armoured GPC3-targeting chimeric antigen receptor T Cells (CAR-T) therapy designed to treat hepatocellular carcinoma (HCC).
Based on drug types, the market is divided into Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Lisocabtagene Maraleuce, Idecabtagene Vicleucel, Ciltacabtegene Autoleucel, and others.
CD19, BCMA, HER2, GD2, CD22, CD30, CD33, HER1 and CLDN18 are common antigens available in the market.
Common application areas include acute lymphocytic leukemia, chronic lymphocytic leukemia, diffuse large B-Cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, glioblastoma, sarcoma, neuroblastoma, acute myeloid leukemia, breast cancer, pancreatic cancer, hepatocellular carcinoma, and colorectal cancer, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Autolus Therapeutics, CARsgen Therapeutics Co.Ltd., Juno Therapeutics, Inc., Sorrento Therapeutics, Inc., Bluebird bio, Inc., CELGENE CORPORATION, Eureka Therapeutics Inc., Avacta Life Sciences Ltd., Calyxt Inc., Celyad Oncology SA, Fortress Biotech, Inc., IMMUNE THERAPEUTICS, INC., Alaunos Therapeutics, Inc., Gilead Sciences, Inc., and Novartis AG.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124